Press Releases
Hardware+Tools Middle East firmly set on growth path
Hardware Tools Middle East looks ahead to a successful 2017 edition, with interest from hardware and tools manufacturers continuing, as market sentiments begin to stabilise across the region. Despite signs of slowing demand in other regions,...
Press Releases
AstraZeneca’s Tagrisso gains full FDA approval for lung cancer
AstraZeneca announced that the US FDA has granted full approval for Tagrisso (osimertinib) 80mg once-daily tablets, for the treatment of patients with metastatic EGFR T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, whose disease...
Press Releases
TraceLink Announces NEXUS 17 Keynote Speakers
TraceLink Inc., the world’s largest Track and Trace Network for connecting the life sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace. Announced the latest keynote speakers confirmed for NEXUS 17, the industry’s...
Press Releases
Botanix receives export and import approvals for clinical studies from DEA
Botanix Pharmaceuticals is pleased to announce that the US Drug Enforcement Agency (DEA) has approved the export, and the Australian Office of Controlled Substances (ODC) has approved the import of synthetic cannabidiol for Botanix’s planned clinical studies. ...
Press Releases
Citius Pharma Announces Addition of South America to World License
Citius Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced that it has recently concluded negotiations to add South America to its worldwide license for Mino-Lok™. ...
Press Releases
Aptar Pharma Preservative-Free Multidose Dispenser Chosen For The First Time For A Prescription Dry Eye Product In The Us With Restasis Multidose
Aptar Pharma’s innovative and patented preservative-free multidose Ophthalmic Squeeze Dispenser is available for patients in the U.S. prescription market for the first time with Allergan’s RESTASIS MULTIDOSE™ (Cyclosporine Ophthalmic Emulsion) 0.05%. Aptar Pharma is working closely with...
Press Releases
Recipharm partners with Sato to manufacture product for Japanese market
Recipharm, the contract development and manufacturing organisation (CDMO), has entered into a long term agreement with Sato Pharmaceutical Co. for the commercial manufacture and delivery of Emla Patch to Japan. Sato, based in Tokyo and founded...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















